Table 8.
F-value | p | |
---|---|---|
(Intercept) | 11502.8 | <.001 |
Cohorts | 39.1 | <.001 |
Follow-up time | 62.5 | <.001 |
Cohorts:Follow-up time | 1.7 | .09 |
The GLMM was utilized to assess the impact of repeated measures on various factors between the two cohorts and across multiple follow-up periods. The statistical differences were assessed using ANOVA, which enabled the identification of both intergroup/intragroup variations. The cohorts included the IgAN-NS (IgAN with NS) and the IgAN-NR (IgAN with nephrotic-range proteinuria). The interaction between cohorts and follow-up periods was denoted as Cohorts * Follow-up duration. Additionally, CR represented complete remission of proteinuria.